DAHANCA - 20 years' cooperation;DAHANCA - 20 års samarbejde

Ugeskrift for Laeger

Volumn 160, Issue 6, 1998, Pages 821-826

  Hansen, Hanne Sand ^a,b   Overgaard, Jens ^a   Jørgensen, Karsten E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOSENSITIZING AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CENTER; CLINICAL TRIAL; DENMARK; HEAD AND NECK TUMOR; HUMAN; INTERNATIONAL COOPERATION; MORTALITY; MULTIMODALITY CANCER THERAPY; ORGANIZATION AND MANAGEMENT; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; STATISTICS; UNITED STATES;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DENMARK; HEAD AND NECK NEOPLASMS; HUMANS; INTERNATIONAL COOPERATION; ONCOLOGY SERVICE, HOSPITAL; RADIATION-SENSITIZING AGENTS; UNITED STATES;

EID: 0032472422     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Storm HH, Manders T, Friis S, Brandt B. Cancer incidence in Denmark 1990, 1991, 1992. Copenhagen: Danish Cancer Society.
2. Henk JM, Kunkler PB, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer Final report of first controlled clinical trial. Lancet 1977; II: 101-3.
3. Adams GE. Hypoxic cell sensitizors for radiotherapy. I: Becker FF, ed. New York: Cancer Plenum Press, 1977, 6: 181-223.
4. Overgaard J, Overgaard M, Timothy AM. Studies of the pharmacokinetic properties of nimorazole. Br J Cancer 1983; 44: 27-34.
5. Cohen L. A cell population kinetic model for fractionated radiation therapy I. Normal tissues. Radiology 1971; 101: 419-27.
6. Hjelm-Hansen M. Laryngeal carcinoma. IV. Analysis of treatment results using Cohen model Acta Radiol Oncol 1980; 19: 3-12.
7. Overgaard J, Andersen AP, Jensen RH, Hjelm-Hansen M, Jørgensen K, Petersen M et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and the pharynx. Acta Otolaryngol (Stochh) 1982, 386: 215-20.
8. Hansen HS, Rygärd J, Andersen AP, Munck-Hansen J, Jørgensen K, Overgaard J et al Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer. DAHANCA I. Acta Oncol 1987; 26: 13-8.
9. Lewin F, Damber L, Jonsson H, Andersson T, Berthelsen A, Björklund A. et al. Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomised phase III study. Radiother Oncol 1997; 43. 23-8.
10. Overgaard J, Hansen HS, Andersen AP, Hjelm-Hansen M, Jørgensen K, Sandberg E et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of la-rynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065-8
11. Melgaard B, Hansen HS, Kamieniecka Z, Paulson OB, Pedersen AG, Tang X et al. Misonidazole neuropathy a clinical, electrophysiological and histological study. Ann Neurol 1982; 12: 10-7.
12. Overgaard J, Hansen HS, Lindeløv B, Overgaard M, Jørgensen K, Rasmusson B et al. Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85. Radiother Oncol 1991; 20 (suppl): 143-9.
13. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779-87.
14. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91
15. Overgaard J, Hjelm-Hansen M, Johansen L Vendelbo, Andersen AP. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147-52.
16. Hansen HS, Overgaard J, Overgaard M, Jørgensen K, Bastholt I, Berthelsen A Continuous versus split-course radiotherapy of advanced supraglottic carcinoma - experience from the Danish Head and Neck Cancer Study (DAHANCA). I: Smee R, Bridger KP, eds. Laryngeal cancer. Proceedings World Congress on Laryngeal Cancer (2nd: 1994 Sydney, NSW). Amsterdam: Elsevier Science, 1994. 465-70.
17. Overgaard J, Hansen HS, Overgaard M, Jørgensen K, Bastholt L, Berthelsen A et al. The Danish Head and Neck Cancer Study Group (DAHANCA), randomized trials with hypoxic radiosensitizers in carcinoma of the larynx and pharynx. I: Dewery WC, ed. Radiation research. A twentieth-century perspective. New York: Academic Press, 1992; 2: 573-7.
18. Horiot JC, Bontemps P, Bogaert Wvd, Fur RL, Weijngaert Dvd, Bolla M et al. Accelerated (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111-21
19. Dische S, Saunders MI, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997; 44: 123-36.
20. Whithers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27. 131-46.